$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
The difference between bimetinib/bemetinib and trametinib
2026-02-01 22:25:32
Check Details
Analysis of the therapeutic effect of Teritusumab/Telivac
2026-02-01 22:25:32
Check Details
FDA approves garadacimab-ANDEMBRY to prevent attacks of hereditary angioedema
2026-02-01 22:25:32
Check Details
Suggestions on how long it will take before the effect of Lynparza is seen after taking it
2026-02-01 22:25:32
Check Details
Is Venetoclax an imported original drug and the authenticity of the drug
2026-02-01 22:25:32
Check Details
Contraindications for taking Asnib/Assiminib (Xinbeli) and who should be cautious
2026-02-01 22:25:32
Check Details
Description of the launch time and approval progress of Ritlecitinib in China
2026-02-01 22:25:32
Check Details
Can sparsentan treat primary IgA nephropathy and its efficacy evaluation
2026-02-01 22:25:32
Check Details
Ixazomib price after medical insurance reimbursement and patient actual payment reference
2026-02-01 22:25:32
Check Details
Clinical therapeutic effects of rubitin/rubicatin (Zanbiga) and patient efficacy feedback
2026-02-01 22:25:32
Check Details
Detailed analysis of the adverse reactions and treatment methods of Pimitespib
2026-02-01 22:25:32
Check Details
Whether afatinib maleate tablets (Afatinib) is a targeted drug and its applicable analysis
2026-02-01 22:25:32
Check Details
1
2
...
2183
2184
2185
2186
2187
2188
2189
...
10213
10214
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Adagrasib Medication Management Guide for Special Populations
2
Olutasidenib (Rezlidhia): A Targeted Drug for IDH1-Mutated Relapsed/Refractory AML
3
Capmatinib Redefines Precision Therapy for MET-Mutated Lung Cancer
4
FDA Approves Dual Immunotherapy Combo: Tecvayli + Darzalex Faspro Transforms RRMM Treatment
5
Cabozantinib: Pivotal Advancements and Global Implications in Multi-Cancer Treatment with Multi-Kinase Inhibition
6
Pretomanid for Drug-Resistant TB: Risks and Management of 3-Year Treatment
7
SKYSCRAPER-02C Study: New Hope for Extensive-Stage Small Cell Lung Cancer Treatment
8
LPCAT3: The Key Player in MASH Progression to Hepatocellular Carcinoma
9
Tucatinib (Tukysa): A Precision Medicine for HER2-Positive Breast & Colorectal Cancer
10
Venetoclax Therapy Guidelines: Balancing Precision Targeting with Risk Management
11
Global Breakthrough: Pralsetinib - Precision Medicine for RET Mutation-Driven Cancers
12
A Comprehensive Guide to Benralizumab Adverse Reactions: Prevention and Management